Ke R - Search Results

1

Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer.

Principe DR, Aissa AF, Kumar S, Pham TND, Underwood PW, Nair R, Ke R, Rana B, Trevino JG, Munshi HG, Benevolenskaya EV, Rana A. Principe DR, et al. Among authors: ke r. Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2200143119. doi: 10.1073/pnas.2200143119. Epub 2022 Apr 27. Proc Natl Acad Sci U S A. 2022. PMID: 35476525 Free PMC article.

2

Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.

Santha S, Davaakhuu G, Basu A, Ke R, Das S, Rana A, Rana B. Santha S, et al. Among authors: ke r. Oncotarget. 2016 Oct 11;7(41):66892-66905. doi: 10.18632/oncotarget.11834. Oncotarget. 2016. PMID: 27602497 Free PMC article.

3

Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells.

Ke R, Vishnoi K, Viswakarma N, Santha S, Das S, Rana A, Rana B. Ke R, et al. Sci Rep. 2018 Apr 3;8(1):5521. doi: 10.1038/s41598-018-23780-x. Sci Rep. 2018. PMID: 29615720 Free PMC article.

4

Berberine Represses β-Catenin Translation Involving 4E-BPs in Hepatocellular Carcinoma Cells.

Vishnoi K, Ke R, Saini KS, Viswakarma N, Nair RS, Das S, Chen Z, Rana A, Rana B. Vishnoi K, et al. Among authors: ke r. Mol Pharmacol. 2021 Jan;99(1):1-16. doi: 10.1124/molpharm.120.000029. Epub 2020 Oct 31. Mol Pharmacol. 2021. PMID: 33130557 Free PMC article.

5

Dysregulation of immune checkpoint proteins in hepatocellular carcinoma: Impact on metabolic reprogramming.

Vishnoi K, Kumar S, Ke R, Rana A, Rana B. Vishnoi K, et al. Among authors: ke r. Curr Opin Pharmacol. 2022 Jun;64:102232. doi: 10.1016/j.coph.2022.102232. Epub 2022 May 5. Curr Opin Pharmacol. 2022. PMID: 35526340 Free PMC article. Review.

6

Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma.

Vishnoi K, Ke R, Viswakarma N, Srivastava P, Kumar S, Das S, Singh SK, Principe DR, Rana A, Rana B. Vishnoi K, et al. Among authors: ke r. Cell Death Dis. 2022 Jul 4;13(7):581. doi: 10.1038/s41419-022-05022-1. Cell Death Dis. 2022. PMID: 35789155 Free PMC article.

7

MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway.

Ke R, Viswakarma N, Menhart M, Singh SK, Kumar S, Srivastava P, Vishnoi K, Kashyap T, Srivastava D, Nair RS, Maienschein-Cline M, Wang X, Rana A, Rana B. Ke R, et al. Oncogene. 2024 Jul;43(30):2307-2324. doi: 10.1038/s41388-024-03055-8. Epub 2024 Jun 10. Oncogene. 2024. PMID: 38858590

8

Molecular insights into the role of mixed lineage kinase 3 in cancer hallmarks.

Ke R, Kumar S, Singh SK, Rana A, Rana B. Ke R, et al. Biochim Biophys Acta Rev Cancer. 2024 Sep;1879(5):189157. doi: 10.1016/j.bbcan.2024.189157. Epub 2024 Jul 18. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39032538 Review.

9

Clinical significance and role of LKB1 in gastric cancer.

Jiang S, Chen R, Yu J, Li N, Ke R, Luo L, Zou J, Zhang J, Zhang K, Lu N, Huang D. Jiang S, et al. Among authors: ke r. Mol Med Rep. 2016 Jan;13(1):249-56. doi: 10.3892/mmr.2015.4508. Epub 2015 Nov 5. Mol Med Rep. 2016. PMID: 26549522

10

Down-regulation of adenosine monophosphate-activated protein kinase activity: A driver of cancer.

He X, Li C, Ke R, Luo L, Huang D. He X, et al. Among authors: ke r. Tumour Biol. 2017 Apr;39(4):1010428317697576. doi: 10.1177/1010428317697576. Tumour Biol. 2017. PMID: 28381161 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters